(Q48572653)

English

Competitiveness in follow-on drug R&D: a race or imitation?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21151030

1 reference

Europe PubMed Central

Competitiveness in follow-on drug R&D: a race or imitation? (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21151030

author name string

Joseph A DiMasi

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21151030

Laura B Faden

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21151030

publication date

10 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21151030

Nature Reviews Drug Discovery

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21151030

10

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21151030

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21151030

23-27

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21151030

Comment on "The economics of follow-on drug research and development: trends in entry rates and the timing of development"

1 reference

https://api.crossref.org/works/10.1038%2FNRD3296

31 March 2020

"Me-too" products--friend or foe?

1 reference

https://api.crossref.org/works/10.1038%2FNRD3296

31 March 2020

The economics of follow-on drug research and development: trends in entry rates and the timing of development

1 reference

https://api.crossref.org/works/10.1038%2FNRD3296

31 March 2020

Was Part D a giveaway to the pharmaceutical industry?

1 reference

https://api.crossref.org/works/10.1038%2FNRD3296

31 March 2020

New drug development in the United States from 1963 to 1999

1 reference

https://api.crossref.org/works/10.1038%2FNRD3296

31 March 2020

Returns on research and development for 1990s new drug introductions

1 reference

https://api.crossref.org/works/10.1038%2FNRD3296

31 March 2020

The price of innovation: new estimates of drug development costs

1 reference

https://api.crossref.org/works/10.1038%2FNRD3296

31 March 2020

Identifiers

10.1038/NRD3296

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21151030

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/21151030

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48572653&oldid=2209602943"